Advanz Pharma Limited Issues Class 2 Recall for Mynzepli 40 mg/mL Solution for Injection

Advanz Pharma Limited has initiated a Class 2 Medicines Recall for specific batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringes. This precautionary measure was issued on October 29, 2026, to address potential quality concerns.